PharmaCielo Ltd.

C$0.06As of Sun 8 Nov 2026, 12:00 UTC
TSXV:PCLOHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR (47.67%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.70
PE TTM —
TSR TTM —
Mkt cap C$12.16M
ROIC (22.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0574
4.39%
(66.29%)
Hold 12|10|7|9|6
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
0.95%
7.73%
18.57%
31.45%
Revenue$M
0.785
0.786
0.806
0.803
8.43%
7.99%
6.86%
7.98%
Peers (US$8.604M)
Cap (US$)
PE
10.24M
—
Capital
TTM
5Y
10Y
Leveragex
2.314
0.340
0.283
EBIT/Intx
2.743
1.609
1.408
Own earn%
(194.87)
22.61
11.96
Sh yield%
20.54
42.45
44.21
Owners
Insiders/Inst%
0.77
38.89
Short interest%
3.82
SBC / revenue%
1.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
10–13
$1 testx
0.1
Incr. ROIC%
2